stockrow
Friday 6 November 2026
Export SDGR’s income statement to Excel — free account
Schrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
29.96
1.19
+4.14%
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) Total debt
Schrodinger, Inc.'s total debt at the end of fiscal 2022 was $116.5M, up 45.9% from $79.9M in fiscal 2021. At the end of the quarter to 30 September 2023 it was $129.0M. Schrodinger, Inc. ranks 16th of 42 Health Information Services companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $116.5M | 45.85% |
| FY2021 | $79.9M | 578.93% |
| FY2020 | $11.8M | (94.29%) |
| FY2019 | $206.1M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2023 | $129.0M | 6.40% |
| Jun 2023 | $121.2M | 4.64% |
| Mar 2023 | $115.9M | (0.53%) |
| Dec 2022 | $116.5M | 21.54% |
| 12 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| TDOC Teladoc Health, Inc. compare | $997.6M |
| GDRX GoodRx Holdings, Inc. compare | $486.6M |
| CERT Certara, Inc. compare | $291.2M |
| HTFL Heartflow, Inc. compare | $182.4M |
| OMCL Omnicell, Inc. compare | $168.5M |
| SDGR Schrodinger, Inc. | $129.0M |
| OMDA Omada Health, Inc. compare | $30.0M |
| HSTM HealthStream, Inc. compare | $21.0M |
| PRVA Privia Health Group, Inc. compare | $5.8M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on SDGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement